
Work Here?
Ampa Health develops neurostimulation tools to treat mental and neurological disorders, centered on the Ampa One system. Ampa One is a portable, camera-guided transcranial magnetic stimulation device for clinicians that targets mood-regulating brain regions to help adults with major depressive disorder who have not responded to antidepressants. Its differences include suitcase portability, a 2.2-pound coil, a subscription model that covers installation, operator training, coil replacements, and telemedicine-ready design to support hub and satellite clinics. The company aims to expand access to non-invasive brain stimulation for major depressive disorder, including treatment-resistant cases, and is pursuing a protocol to shorten multi-week therapy into a single day, pending FDA clearance.
We're working on gathering enough insights on this company, check back soon!
Industries
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$8.5M
Headquarters
Palo Alto, California
Founded
2022
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$8.5M
Above
Industry Average
Funded Over
1 Rounds
Industry standards
Company Equity
Find jobs on Simplify and start your career today
We're working on gathering enough insights on this company, check back soon!
Industries
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$8.5M
Headquarters
Palo Alto, California
Founded
2022
Find jobs on Simplify and start your career today